Cassava Sciences has officially ended development of simufilam in Alzheimer’s disease, marking the end of a tumultuous era ...

(Reuters) -Cassava Sciences said on Tuesday its Alzheimer's drug simufilam, which has been at the center of regulatory ...

Chances are you're here because while watching the NCAA men's tournament, you noticed Wofford center Kyler Filewich shooting ...

Kyler Filewich doesn’t go to the free throw line looking for style points, just those that count on the scoreboard for ...

We are disappointed that the results of REFOCUS-ALZ and RETHINK-ALZ showed no treatment benefit for patients with mild-to-moderate Alzheimer’s ...